Guess Who Picked Rave Restaurant Group Inc. (NASDAQ:RAVE) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Rave Restaurant Group Inc. (NASDAQ:RAVE) reported that Newcastle Partners L P. has picked up 2,481,864 of common stock as of 2017-03-23.
The acquisition brings the aggregate amount owned by Newcastle Partners L P. to a total of 2,481,864 representing a 21.9% stake in the company.
For those not familiar with the company, Rave Restaurant Group, Inc. operates and franchises pizza buffet, delivery/carry-out and express restaurants domestically and internationally under the trademark, Pizza Inn, and operates and franchises domestic fast casual restaurants under the trademarks Pie Five Pizza Company (Pie Five). The Company has two operating segments, which include Company-owned Restaurants, and Franchising and Food and Supply Distribution. The Franchising and Food and Supply Distribution segment establishes franchisees and franchise territorial rights, and sells and distributes proprietary and non-proprietary food and other items to franchisees. The Company-owned Restaurant segment includes sales and operating results for all Company-owned restaurants. It provides or facilitates the procurement and distribution of food, equipment and supplies to domestic and international system of restaurants through Norco Restaurant Services Company (Norco) division and through agreements with third-party distributors.
A glance at Rave Restaurant Group Inc. (NASDAQ:RAVE)’s key stats reveals a current market capitalization of 19.01 Million based on 10.66 Million shares outstanding and a price at last close of $1.78 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-03-08, Crane picked up 4,000 at a purchase price of $2.09. This brings their total holding to 5,000 as of the date of the filing.
On the sell side, the most recent transaction saw Mullany unload 11,000 shares at a sale price of $3.03. This brings their total holding to 10,980.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Rave Restaurant Group Inc. (NASDAQ:RAVE) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Here’s Who Just Picked Up Gastar Exploration Inc. (NYSEMKT:GST) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Gastar Exploration Inc. (NYSEMKT:GST) reported that Ares Management Llc. has picked up 10,302,272 of common stock as of 2017-03-23.
The acquisition brings the aggregate amount owned by Ares Management Llc. to a total of 10,302,272 representing a 5.5% stake in the company.
For those not familiar with the company, Gastar Exploration Inc. is an independent energy company engaged in the exploration, development and production of oil, condensate, natural gas and natural gas liquids in the United States. Gastar’s principal assets are in Oklahoma, referred to as its Mid-Continent area, where it is developing the primarily oil-bearing reservoirs of the Hunton Limestone horizontal play and testing the Meramec Shale/Middle Mississippi Lime formation. Gastar believes its Mid-Continent acreage is prospective for the Meramec Shale/Mississippi Lime formation, the Woodford Shale and the Osage and Oswego formations, which Gastar collectively refers to as the Mid-Continent STACK Play.
A glance at Gastar Exploration Inc. (NYSEMKT:GST)’s key stats reveals a current market capitalization of 251.27 Million based on 186.12 Million shares outstanding and a price at last close of $1.39 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-01-14, Global picked up 500,000 at a purchase price of $1.21. This brings their total holding to 10,149,519 as of the date of the filing.
On the sell side, the most recent transaction saw Global unload 1,500,000 shares at a sale price of $0.91. This brings their total holding to 8,500,000.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Gastar Exploration Inc. (NYSEMKT:GST) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Richmond Brothers, Inc. Picked Rockwell Medical Inc. (NASDAQ:RMTI) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Rockwell Medical Inc. (NASDAQ:RMTI), reported that Richmond Brothers, Inc. has picked up 5,172,452 of common stock as of 2017-03-23.
The acquisition brings the aggregate amount owned by Richmond Brothers, Inc. to a total of 5,172,452 representing a 10.0% stake in the company.
For those not familiar with the company, Rockwell Medical, Inc. (Rockwell) is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Company operates through the hemodialysis market segment, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceutical, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its lead branded drug, Triferic is indicated for iron maintenance. Triferic is an iron compound that is delivered to hemodialysis patients through dialysate, replacing the iron loss that occurs during their dialysis treatment. Its generic drug, Calcitriol, is indicated for treating secondary hyperparathyroidism in dialysis patients. It manufactures, sells, delivers and distributes hemodialysis concentrates, along with a range of ancillary products.
A glance at Rockwell Medical Inc. (NASDAQ:RMTI)’s key stats reveals a current market capitalization of 315.74 Million based on 51.53 Million shares outstanding and a price at last close of $5.88 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-03-22, Richmond picked up 21,076 at a purchase price of $5.94. This brings their total holding to 29,802 as of the date of the filing.
On the sell side, the most recent transaction saw Holt unload 3,200 shares at a sale price of $5.97. This brings their total holding to 12,630.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Rockwell Medical Inc. (NASDAQ:RMTI) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Guess Who Picked Up Novocure Ltd. (NASDAQ:NVCR) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Novocure Ltd. (NASDAQ:NVCR), reported that Pomona Capital Vii, L.p. has picked up 9,874,860 of common stock as of 2017-03-23.
The acquisition brings the aggregate amount owned by Pomona Capital Vii, L.p. to a total of 9,874,860 representing a 11.3% stake in the company.
For those not familiar with the company, NovoCure Limited is a commercial-stage oncology company. The Company is engaged in developing a therapy called TTFields for the treatment of solid tumor cancers. TTFields is a low-toxicity anti-mitotic treatment that uses low-intensity, intermediate frequency, alternating electric fields to exert physical forces on molecules inside cancer cells, disrupting the basic machinery for normal cell division, leading to cancer cell death. A TTFields delivery system includes a portable electric field generator, transducer arrays, rechargeable batteries and accessories. The electric fields are delivered through the non-invasive, insulated transducer arrays that are placed directly on the skin in the region surrounding the tumor. The therapy is designed to be delivered throughout the day and night. The Company has performed various pre-clinical research on TTFields and their effects in multiple solid tumor cancers.
A glance at Novocure Ltd. (NASDAQ:NVCR)’s key stats reveals a current market capitalization of 592.22 Million based on 87.07 Million shares outstanding and a price at last close of $6.90 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-03-21, Perlhagen picked up 125,000 at a purchase price of $6.93. This brings their total holding to 6,125,000 as of the date of the filing.
On the sell side, the most recent transaction saw Ambrogi unload 7,500 shares at a sale price of $8.09. This brings their total holding to 131,584.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Novocure Ltd. (NASDAQ:NVCR) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Here’s Who Just Picked Up Intrepid Potash Inc. (NYSE:IPI) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Intrepid Potash Inc. (NYSE:IPI), reported that Harvey Operating & Production Co. has picked up 11,751,383 of common stock as of 2017-03-23.
The acquisition brings the aggregate amount owned by Harvey Operating & Production Co. to a total of 11,751,383 representing a 9.1% stake in the company.
For those not familiar with the company, Intrepid Potash, Inc. is a producer of muriate of potash (potassium chloride or potash) and langbeinite (sulfate of potash magnesia) in the United States, which it markets and sells as Trio. The Company operates in the extraction, production and sale of potassium containing products segment. Its products are potash and Trio. The Company also produces salt, magnesium chloride and metal recovery salts from its potash mining processes. It owns approximately three solution mining facilities and over two conventional underground facilities that are utilized for producing potash. Its solution mining production comes from the HB mine near Carlsbad, New Mexico, a solution mine near Moab, Utah, and a brine recovery mine in Wendover, Utah. The Company’s production comes from its underground West and East mines near Carlsbad, New Mexico.
A glance at Intrepid Potash Inc. (NYSE:IPI)’s key stats reveals a current market capitalization of 191.08 Million based on 79.28 Million shares outstanding and a price at last close of $1.65 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-03-21, Martin picked up 3,150,000 at a purchase price of $1.20. This brings their total holding to 3,233,709 as of the date of the filing.
On the sell side, the most recent transaction saw Considine unload 29,921 shares at a sale price of $1.29. This brings their total holding to 123,535.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Intrepid Potash Inc. (NYSE:IPI) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Guess Who Picked Blue Bird Corp (NASDAQ:BLBD) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Blue Bird Corp (NASDAQ:BLBD) reported that Coliseum Capital has picked up 2,241,426 of common stock as of 2017-03-22.
The acquisition brings the aggregate amount owned by Coliseum Capital to a total of 2,241,426 representing a 9.5% stake in the company.
For those not familiar with the company, Hennessy Capital LLC is an alternative investment platform focused on industrial sector opportunities utilizing unique and proprietary investment vehicles and strategies.
A glance at Blue Bird Corp (NASDAQ:BLBD)’s key stats reveals a current market capitalization of 375.39 Million based on 23.03 Million shares outstanding and a price at last close of $16.30 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-06-08, Asp picked up 5,000,0000 at a purchase price of $11.00. This brings their total holding to 12,000,000 as of the date of the filing.
On the sell side, the most recent transaction saw Coliseum unload 50,000 shares at a sale price of $17.00. This brings their total holding to 1,122,615.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Blue Bird Corp (NASDAQ:BLBD) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Here’s Who Just Picked Up Therapeuticsmd Inc. (NYSEMKT:TXMD) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Therapeuticsmd Inc. (NYSEMKT:TXMD) reported that Smith Robert J has picked up 12,157,505 of common stock as of 2017-03-22.
The acquisition brings the aggregate amount owned by Smith Robert J to a total of 12,157,505 representing a 6.15% stake in the company.
For those not familiar with the company, TherapeuticsMD, Inc. is a women’s healthcare company engaged in creating and commercializing products for women. The Company is focused on pursuing regulatory approvals and pre-commercialization activities necessary for commercialization of its hormone therapy pharmaceutical products. Its drug candidates used in clinical trials are designed to alleviate symptoms of and reduce health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis and vaginal discomfort. With its SYMBODA technology, it is developing hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through dosage forms and administration routes. Its product line includes vitaTrue, vitaPearl, vitaMedMD Plus, vitaMedMD One Prenatal Multivitamin, vitaMedMD Plus Rx Prenatal Multivitamin, vitaMedMD One Rx Prenatal Multivitamin, vitaMedMD Iron 21/7, vitaMedMD Vitamin D3 50,000 IU, BocaGreenMD Prena1 Pearl and BocaGreenMD Prena1 Chew.
A glance at Therapeuticsmd Inc. (NYSEMKT:TXMD)’s key stats reveals a current market capitalization of 1.22 Billion based on 197.52 Million shares outstanding and a price at last close of $6.42 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-03-11, Collins picked up 16,000 at a purchase price of $6.23. This brings their total holding to 36,000 as of the date of the filing.
On the sell side, the most recent transaction saw Krassan unload 30,000 shares at a sale price of $8.18. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Therapeuticsmd Inc. (NYSEMKT:TXMD) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Red Robin Gourmet Burgers Inc. (NASDAQ:RRGB) is Attracting Smart Money
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Red Robin Gourmet Burgers Inc. (NASDAQ:RRGB) reported that Integrated Core Strategies (us) Llc. has picked up 535,489 of common stock as of 2017-03-22.
The acquisition brings the aggregate amount owned by Integrated Core Strategies (us) Llc. to a total of 535,489 representing a 4.2% stake in the company.
For those not familiar with the company, Red Robin Gourmet Burgers, Inc., together with its subsidiaries, primarily develops, operates, and franchises full-service restaurants in North America and focuses on serving selection of gourmet burgers. The Company’s menu features a line of gourmet burgers, which it makes from ground beef, as well as its line of Red’s Tavern Double Burgers and its Red Robin’s line of half-pound Angus beef burgers with various toppings. The Company also offers burgers made from chicken breasts, fish fillets, turkey patties, as well as vegetarian and vegan options. The Company offered a selection of buns, including ciabatta, gluten free, sesame, onion, whole grain, jalapeno and lettuce wraps a range of toppings, including fresh guacamole, house made barbeque sauces, aiolis, grilled pineapple, crispy onion straws, sauteed mushrooms, fried jalapenos, bruschetta salsa, coleslaw, eight different cheese choices and a fried egg, as of December 25, 2016.
A glance at Red Robin Gourmet Burgers Inc. (NASDAQ:RRGB)’s key stats reveals a current market capitalization of 681.76 Million based on 12.86 Million shares outstanding and a price at last close of $53.70 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-03-02, Connors picked up 1,100 at a purchase price of $47.90. This brings their total holding to 4,115 as of the date of the filing.
On the sell side, the most recent transaction saw Howell unload 3,000 shares at a sale price of $55.33. This brings their total holding to 23,068.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Red Robin Gourmet Burgers Inc. (NASDAQ:RRGB) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.